Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma

Tanaya Shree, Sarah Haebe, Debra K. Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe, Susan M. Grimes, Matthew J Frank, Lauren S. Maeda, Ash A. Alizadeh, Ranjana H. Advani, Richard Hoppe, Steven R. Long, Brock Martin, Michael G. Ozawa, Michael S. Khodadoust, Hanlee P. Ji, Ronald Levy

Blood (2022) 140 (Supplement 1): 6450–6451.

https://doi.org/10.1182/blood-2022-167469

Published: 2022

Journal Articles

Investigating Metabolic Response after CAR-T Therapy and Bridging Radiotherapy for Relapsed/Refractory B-Cell Lymphoma

Mallika Marar, Susan Hiniker, Richard Hoppe, Michael Binkley

Blood (2022) 140 (Supplement 1): 12786–12787.

https://doi.org/10.1182/blood-2022-165302

Published: 2022

Journal Articles

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

Blood (2022) 140 (Supplement 1): 1756–1758.

https://doi.org/10.1182/blood-2022-156382

Published: 2022

Journal Articles

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Blood (2022) 140 (5): 419–437.

https://doi.org/10.1182/blood.2021012057

Published: 2022

Journal Articles

Therapeutic and Immunologic Responses Elicited By in Situ Vaccination with CpG, Ibrutinib, and Low-Dose Radiation

Tanaya Shree, Sarah Haebe, Debra K. Czerwinski, Grady Day, Anuja Sathe, Michael S. Khodadoust, Matthew J. Frank, Sara Beygi, Richard Hoppe, Steven R. Long, Brock Martin, Hanlee P. Ji, Ronald Levy

Blood (2021) 138 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2021-154017

Published: 2021

Journal Articles

In Situ Vaccination Induces Changes in Follicular Lymphoma Tumor Cells That Correlate with Abscopal Clinical Regressions

Sarah Haebe, Tanaya Shree, Grady Day, Anuja Sathe, Debra K. Czerwinski, Susan M. Grimes, Steven R. Long, Brock Martin, Richard Hoppe, Hanlee P. Ji, Ronald Levy

Blood (2021) 138 (Supplement 1): 2407.

https://doi.org/10.1182/blood-2021-154115

Published: 2021

Journal Articles

How I treat mycosis fungoides and Sézary syndrome

Sean Whittaker, Richard Hoppe, H. Miles Prince

Blood (2016) 127 (25): 3142–3153.

https://doi.org/10.1182/blood-2015-12-611830

Published: 2016

Journal Articles

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Leo I Gordon, MD, FACP, Fanxing Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Mary Gospodarowicz, MD, FRCPC, Ranjana Advani, MD, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, Richard Hoppe, MD, Sandra J. Horning, MD

Blood (2010) 116 (21): 415.

https://doi.org/10.1182/blood.V116.21.415.415

Published: 2010

Journal Articles

Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

Ranjana Advani, MD, Fangxin Hong, PhD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Sue Robinson, MD, Randy D. Gascoyne, MD, Henry Wagner, MD, Patrick J Stiff, MD, Bruce D. Cheson, MD, Douglas A. Stewart, MD, FRCP, Leo I Gordon, MD, FACP, Brad Kahl, MD, Jonathan W. Friedberg, MD, Kristie A. Blum, MD, Thomas M. Habermann, MD, Joseph Tuscano, MD, Richard Hoppe, MD, Sandra J. Horning, MD

Blood (2010) 116 (21): 416.

https://doi.org/10.1182/blood.V116.21.416.416

Published: 2010

Journal Articles

Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin.

Robert Lowsky, MD, Judith Shizuru, MD, PhD, Stephan Busque, MD, John Scandling, MD, Minnie Sarwal, MD, Sussan Jones, Claudia Benike, Richard Hoppe, MD, Ed Engleman, MD, Sam Strober, MD

Blood (2008) 112 (11): 2174.

https://doi.org/10.1182/blood.V112.11.2174.2174

Published: 2008

Journal Articles

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.

Denise Woo, MD, Chris Jones, MD, Monique Vanoli-Storz, MD, Sabine Kohler, MD, Sunil Reddy, MD, Ranjana Advani, MD, Richard Hoppe, MD, Youn Kim, MD

Blood (2007) 110 (11): 3573.

https://doi.org/10.1182/blood.V110.11.3573.3573

Published: 2007

Journal Articles

Bexarotene Is Highly Active in the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Ana M. Molina, MD, Ranjana Advani, MD, Sunil Reddy, MD, Richard Hoppe, MD, Jonathan W. Friedberg, MD, Sara Sadan, MD, Patricia Myskowski, MD, Youn H. Kim, MD, Steven M. Horwitz, MD

Blood (2005) 106 (11): 3344.

https://doi.org/10.1182/blood.V106.11.3344.3344

Published: 2005

Journal Articles

Long-Term Depletion of Naive T Cells in Patients Treated for Hodgkin's Disease

Nobukazu Watanabe, Stephen C. De Rosa, Anthony Cmelak, Richard Hoppe, Leonore A. Herzenberg, Leonard A. Herzenberg, Mario Roederer

Blood (1997) 90 (9): 3662–3672.

https://doi.org/10.1182/blood.V90.9.3662

Published: 1997

NARROW

Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma

Investigating Metabolic Response after CAR-T Therapy and Bridging Radiotherapy for Relapsed/Refractory B-Cell Lymphoma

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Therapeutic and Immunologic Responses Elicited By in Situ Vaccination with CpG, Ibrutinib, and Low-Dose Radiation

In Situ Vaccination Induces Changes in Follicular Lymphoma Tumor Cells That Correlate with Abscopal Clinical Regressions

How I treat mycosis fungoides and Sézary syndrome

A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496

Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin.

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.

Bexarotene Is Highly Active in the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Long-Term Depletion of Naive T Cells in Patients Treated for Hodgkin's Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only